Global Radiation Oncology Market By Type (External Beam Radiation Therapy, Internal Beam Radiation Therapy and Systemic Radiotherapy), Application (External Beam Radio Therapy and Brachytherapy), End Users (Hospitals and Independent Radiotherapy Centers): Global Industry Perspective, Comprehensive Analysis and Forecast, 2020 – 2026

Description

The Radiation Oncology market is set for a rapid growth over the forecast period. In terms of revenue, the global Radiation Oncology market was valued at USD 6.6 billion in 2019 and is expected to register a CAGR of 7.3% from 2020 to 2026.

Global Radiation Oncology Market: Overview

Radiation Therapy is used in the treatment of cancer. The therapy uses waves of energy such as light and heat to shrink tumors and destroy the genetic material that controls how cells grow and divide. The radiation therapy is also referred as external beam radiation therapy. The treatment helps in curing the deadly disease but it also has side effects such as nausea and vomiting, intestinal discomfort, infertility, etc.

Global Radiation Oncology Market: Growth Factors

The radiation oncology market is expected to flourish due to factors such as rising demand of radiotherapy, technological advancements in radiotherapy, and increase awareness of the cancer treatment. The Covid-19 impacted all the market due to safety measures taken by the government such as lockdown, social distancing but the planned model by the government and hospitals resulted in continuity of radiotherapy treatment as well maintaining a safer environment for the patients. This has also resulted in the smooth functioning of the radiation oncology market. Driving factors such as increased investment by the government and improved reimbursement scenario will also contribute towards the growth of the radiation oncology market. Rise in Cancer cases is also driving the market of radiation oncology.

Global Radiation Oncology Market: Segmentation

The Global Radiation Oncology Market is segmented into Type, Application and End Users. On the basis of type, the global radiation oncology market is segmented into External Beam Radiation Therapy, Internal Beam Radiation Therapy and Systemic Radiotherapy. By Application, the global radiation oncology market is fragmented into External Beam Radio Therapy and Brachytherapy. Based on End Users, the global radiation oncology market is divided into Hospitals and Independent Radiotherapy Centers.

Global Radiation Oncology Market: Regional Analysis

Based on regions, the global Radiation Oncology market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America dominated the global market for radiation oncology due to advanced healthcare infrastructure, high healthcare expenditure, and significant R&D carried out in radiation oncology. The Asia Pacific is expected to witness the highest growth over the forecast period due to launch of new radiation oncology therapy systems in medical centers and hospitals, strategic initiatives undertaken by key players to strengthen their presence in the region is expected to boost the market growth.

Global Radiation Oncology Market: Competitive Players

Some of the key players operating in the market include Varian Medical Systems, Inc. , Elekta (Sweden), Accuray Incorporated , Ion Beam Applications SA (Belgium), ViewRay, Inc. , IsoRay Medical, Inc. , Hitachi Ltd. (Japan), Panacea Medical Technologies Pvt. Ltd. (India), Provision Healthcare , and Mevion Medical Systems, Inc. among others. The key players are focusing on taking various initiatives such as product expansion, mergers and acquisitions, licensing, etc. to gain competitive edge in the market.

The global Radiation Oncology market is segmented as follows:

By Type

• External Beam Radiation Therapy
• Internal Beam Radiation Therapy
• Systemic Radiotherapy

By Application

• External Beam Radio Therapy
• Brachytherapy

By End Users

• Hospitals
• Independent Radiotherapy Centers

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa

Table Of Content

• Chapter 1.Preface
  • 1.1.Report Description
  • 1.1.Report Scope
• Chapter 2.Research Methodulogy
  • 2.1.Research Methodulogy
  • 2.2.Secondary Research
  • 2.3.Primary Research
  • 2.4.Models
    • 2.4.1.Company Share Analysis Model
    • 2.4.2.Revenue Based Modeling
  • 2.5.Research Limitations
• Chapter 3.Executive Summary
  • 3.1.Global Radiation Onculogy Market, 2016 – 2026 (Million)
  • 3.2.Global Radiation Onculogy Market: Snapshot
• Chapter 4.Radiation Onculogy Market – Industry Analysis
  • 4.1.Introduction
  • 4.2.Market Drivers
    • 4.2.1.Driving Factor 1 Analysis
    • 4.2.2.Driving Factor 2 Analysis:
  • 4.3.Market Restraints
    • 4.3.1.Restraining Factor Analysis
  • 4.4.Market Opportunities
    • 4.4.1.Market Opportunity & Use-case Analyses
    • 4.4.2.Use – Cases for Radiation Onculogy
  • 4.5.Porter’s Five Forces Analysis
  • 4.6.COVID 19 Impact Analysis
    • 4.6.1.1.Impact on Product Development and Technulogy Adoption
    • 4.6.1.2.Gap Analysis

• Chapter 5.Investment Proposition Analysis
  • 5.1.Global Radiation Onculogy Market Attractiveness, By Type
  • 5.2.Global Radiation Onculogy Market Attractiveness, By Application
  • 5.3.Global Radiation Onculogy Market Attractiveness, By End Users
  • 5.4.Global Radiation Onculogy Market Attractiveness, By Region
• Chapter 6.Competitive Landscape
  • 6.1.Company Market Share Analysis - 2019
    • 6.1.1.Global Radiation Onculogy Market: Company Market Share, 2019
  • 6.2.Strategic Developments
  • 7.1.Global Radiation Onculogy Market Overview: by Type
    • 7.1.1.Global Radiation Onculogy Market Revenue Share, by Type, 2019 & 2026
  • 7.2.Global Radiation Onculogy Market Analysis/Overview – By Type
    • 7.2.1.External Beam Radiation Therapy – Overview/Analysis
    • 7.2.2.Internal Beam Radiation Therapy – Overview/Analysis
    • 7.2.3.Systemic Radiotherapy – Overview/Analysis
  • 7.3.External Beam Radiation Therapy
    • 7.3.1.Global Radiation Onculogy Market for External Beam Radiation Therapy, Revenue (Million) 2016 - 2026
  • 7.4.Internal Beam Radiation Therapy
    • 7.4.1.Global Radiation Onculogy Market for Internal Beam Radiation Therapy, Revenue (Million) 2016 - 2026
  • 7.5.Systemic Radiotherapy
    • 7.5.1.Global Radiation Onculogy Market for Systemic Radiotherapy, Revenue (Million) 2016 - 2026
  • 8.1.Global Radiation Onculogy Market Overview: by Application
    • 8.1.1.Global Radiation Onculogy Market Revenue Share, by Application, 2019 & 2026
  • 8.2.Global Radiation Onculogy Market Analysis/Overview – By Application
    • 8.2.1.External Beam Radio Therapy – Overview/Analysis
    • 8.2.2.Brachytherapy – Overview/Analysis
  • 8.3.External Beam Radio Therapy
    • 8.3.1.Global Radiation Onculogy Market for External Beam Radio Therapy, Revenue (Million) 2016 - 2026
  • 8.4.Brachytherapy
    • 8.4.1.Global Radiation Onculogy Market for Brachytherapy, Revenue (Million) 2016 - 2026
  • 9.1.Global Radiation Onculogy Market Overview: by End Users
    • 9.1.1.Global Radiation Onculogy Market Revenue Share, by End Users, 2019 & 2026
  • 9.2.Global Radiation Onculogy Market Analysis/Overview – By End Users
    • 9.2.1.Hospitals – Overview/Analysis
    • 9.2.2.Independent Radiotherapy Centers – Overview/Analysis
  • 9.3.Hospitals
    • 9.3.1.Global Radiation Onculogy Market for Hospitals, Revenue (Million) 2016 - 2026
  • 9.4.Independent Radiotherapy Centers
    • 9.4.1.Global Radiation Onculogy Market for Independent Radiotherapy Centers, Revenue (Million) 2016 - 2026
• Chapter 10.Radiation Onculogy Market – Regional Analysis
  • 10.1.Global Radiation Onculogy Market: Regional Overview
    • 10.1.1.Global Radiation Onculogy Market Revenue Share, by Region, 2019 & 2026
    • 10.1.2.Global Radiation Onculogy Market Revenue, by Region, 2016 – 2026 (Million)
  • 10.2.North America
    • 10.2.1.North America Radiation Onculogy Market Revenue, 2016 - 2026 (Million)
    • 10.2.2.North America Radiation Onculogy Market Revenue, by Country, 2016 – 2026 (Million)
    • 10.2.3.North America Radiation Onculogy Market Revenue, by Type, 2016 – 2026
    • 10.2.4.North America Radiation Onculogy Market Revenue, by Application, 2016 – 2026
    • 10.2.5.North America Radiation Onculogy Market Revenue, by End Users, 2016 – 2026
    • 10.2.6. U.S.
    • 10.2.7.Canada
  • 10.3.Europe
    • 10.3.1.Europe Radiation Onculogy Market Revenue, 2016 - 2026 (Million)
    • 10.3.2.Europe Radiation Onculogy Market Revenue, by Country, 2016 – 2026 (Million)
    • 10.3.3.Europe Radiation Onculogy Market Revenue, by Type, 2016 – 2026
    • 10.3.4.Europe Radiation Onculogy Market Revenue, by Application, 2016 – 2026
    • 10.3.5.Europe Radiation Onculogy Market Revenue, by End Users, 2016 – 2026
    • 10.3.6.Germany
    • 10.3.7.France
    • 10.3.8. U.K.
    • 10.3.9.Italy
    • 10.3.10.Spain
    • 10.3.11.Rest of Europe
  • 10.4.Asia Pacific
    • 10.4.1.Asia Pacific Radiation Onculogy Market Revenue, 2016 - 2026 (Million)
    • 10.4.2.Asia Pacific Radiation Onculogy Market Revenue, by Country, 2016 – 2026 (Million)
    • 10.4.3.Asia Pacific Radiation Onculogy Market Revenue, by Type, 2016 – 2026
    • 10.4.4.Asia Pacific Radiation Onculogy Market Revenue, by Application, 2016 – 2026
    • 10.4.5.Asia Pacific Radiation Onculogy Market Revenue, by End Users, 2016 – 2026
    • 10.4.6.China
    • 10.4.7.Japan
    • 10.4.8.India
    • 10.4.9.South Korea
    • 10.4.10.South-East Asia
    • 10.4.11.Rest of Asia Pacific
  • 10.5.Latin America
    • 10.5.1.Latin America Radiation Onculogy Market Revenue, 2016 - 2026 (Million)
    • 10.5.2.Latin America Radiation Onculogy Market Revenue, by Country, 2016 – 2026 (Million)
    • 10.5.3.Latin America Radiation Onculogy Market Revenue, by Type, 2016 – 2026
    • 10.5.4.Latin America Radiation Onculogy Market Revenue, by Application, 2016 – 2026
    • 10.5.5.Latin America Radiation Onculogy Market Revenue, by End Users, 2016 – 2026
    • 10.5.6.Brazil
    • 10.5.7.Mexico
    • 10.5.8.Rest of Latin America
  • 10.6.The Middle-East and Africa
    • 10.6.1.The Middle-East and Africa Radiation Onculogy Market Revenue, 2016 - 2026 (Million)
    • 10.6.2.The Middle-East and Africa Radiation Onculogy Market Revenue, by Country, 2016 – 2026 (Million)
    • 10.6.3.The Middle-East and Africa Radiation Onculogy Market Revenue, by Type, 2016 – 2026
    • 10.6.4.The Middle-East and Africa Radiation Onculogy Market Revenue, by Application, 2016 – 2026
    • 10.6.5.The Middle-East and Africa Radiation Onculogy Market Revenue, by End Users, 2016 – 2026
    • 10.6.6.GCC Countries
    • 10.6.7.South Africa
    • 10.6.8.Rest of Middle-East Africa
• Chapter 11.Company Profiles
  • 11.1.Varian Medical Systems, Inc.
  • 11.2.Elekta
  • 11.3.Accuray Incorporated
  • 11.4.Ion Beam Applications SA
  • 11.5.ViewRay, Inc.
  • 11.6.IsoRay Medical, Inc.
  • 11.7.Hitachi Ltd.
  • 11.8.Panacea Medical Technulogies Pvt. Ltd.
  • 11.9.Provision Healthcare
  • 11.1.Mevion Medical Systems, Inc.

Methodology